Smith Nicholas Conrad

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 9. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 9
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Alto Neuroscience, Inc.PRESIDENT AND CFOOption exercisenothing paid24,056 sharesOct 1, 2026Alto Neuroscience, Inc.PRESIDENT AND CFOnothing paidExercise · Oct 1Option exercise24,056Oct 1, 2026
Alto Neuroscience, Inc.PRESIDENT AND CFOOption exercisenothing paid54,375 sharesOct 1, 2026Alto Neuroscience, Inc.PRESIDENT AND CFOnothing paidExercise · Oct 1Option exercise54,375Oct 1, 2026
Alto Neuroscience, Inc.PRESIDENT AND CFOOption exercisenothing paid56,455 sharesOct 1, 2026Alto Neuroscience, Inc.PRESIDENT AND CFOnothing paidExercise · Oct 1Option exercise56,455Oct 1, 2026
Alto Neuroscience, Inc.PRESIDENT AND CFOOpen-market sell$23,807886 sharesOct 1, 2026Alto Neuroscience, Inc.PRESIDENT AND CFO$23,807Sell · Oct 1Open-market sell886Oct 1, 2026
Alto Neuroscience, Inc.PRESIDENT AND CFOOpen-market sell$597,29023,170 sharesOct 1, 2026Alto Neuroscience, Inc.PRESIDENT AND CFO$597,290Sell · Oct 1Open-market sell23,170Oct 1, 2026